Tenet Healthcare (NYSE:THC) Releases FY 2026 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 16.380-18.68 for the period, compared to the consensus estimate of 17.220. The company issued revenue guidance of $21.5 billion-$22.3 billion, compared to the consensus revenue estimate of $22.0 billion.

Tenet Healthcare Stock Performance

Shares of THC traded down $3.08 during mid-day trading on Thursday, hitting $177.02. 3,311,799 shares of the company’s stock were exchanged, compared to its average volume of 1,265,857. Tenet Healthcare has a fifty-two week low of $140.28 and a fifty-two week high of $247.21. The firm has a market capitalization of $15.51 billion, a P/E ratio of 11.43, a P/E/G ratio of 1.35 and a beta of 1.49. The business’s 50 day moving average is $207.31 and its two-hundred day moving average is $204.17. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.19 by $0.63. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.40 billion. During the same quarter in the prior year, the firm earned $4.36 earnings per share. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities analysts expect that Tenet Healthcare will post 17.31 earnings per share for the current year.

Analyst Ratings Changes

THC has been the subject of several recent research reports. Weiss Ratings reiterated a “buy (b-)” rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Wells Fargo & Company reiterated an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. Truist Financial increased their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Leerink Partners increased their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. Finally, Guggenheim increased their price target on shares of Tenet Healthcare from $271.00 to $283.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $250.56.

Insider Transactions at Tenet Healthcare

In other news, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 46,517 shares of company stock valued at $10,943,111 in the last ninety days. Corporate insiders own 0.81% of the company’s stock.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong M&A deployment — Tenet invested roughly $125M to buy seven ASCs in Q1, signaling an aggressive ambulatory expansion strategy that can lift margins and volume over time. Tenet deployed $125M on 7 ASC acquisitions in Q1, eyes more deals
• Positive Sentiment: Procedure mix improvement — Tenet’s ASC acuity push is producing double‑digit joint replacement growth and it now runs 150+ robotic surgery programs, supporting higher‑margin outpatient volumes. Double-digit joint replacement growth, 150+ robotic surgery programs: Tenet’s ASC acuity push is paying off
• Positive Sentiment: Operational resilience — Management credited “old‑fashioned discipline” for navigating Q1 volume volatility, suggesting the company can protect margins through execution. Tenet Healthcare met Q1’s volume curveballs with ‘old-fashioned discipline’
• Neutral Sentiment: Earnings vs revenue mix — Tenet reported Q1 EPS of $4.82 (beat) but revenue of $5.37B missed estimates; management released FY‑2026 EPS guidance of roughly $16.38–$18.68 (around consensus) and revenue guidance modestly below consensus — the range leaves upside and downside for investors. Tenet Healthcare (THC) Q1 Earnings Top Estimates
• Negative Sentiment: Payer/admissions mix pressure — Management attributed softer sales to an unfavorable admissions and payer mix plus external disruptions, which trimmed revenue growth and is the main reason the stock is down despite the EPS beat. Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales

Institutional Trading of Tenet Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of THC. NewEdge Advisors LLC grew its stake in Tenet Healthcare by 6.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after acquiring an additional 166 shares during the period. Jones Financial Companies Lllp grew its stake in Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares during the period. Sivia Capital Partners LLC purchased a new stake in Tenet Healthcare in the 2nd quarter worth approximately $290,000. Quantbot Technologies LP purchased a new stake in Tenet Healthcare in the 2nd quarter worth approximately $65,000. Finally, Amundi boosted its holdings in shares of Tenet Healthcare by 4,207.8% in the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.